EUVIMEDEUVIMED entdecken
Open Access

Regulation of VKORC1L1 is critical for p53-mediated tumor suppression through vitamin K metabolism

Xin Yang, Zhe Wang, Fereshteh Zandkarimi, Yanqing Liu, Shoufu Duan, Zhiming Li, Ning Kon, Zhiguo Zhang, Xuejun Jiang, Brent R Stockwell, Wei Gu

Cell Metabolism · 2023-08 · 35 (8) · 1474-1490.e8

DOI: 10.1016/j.cmet.2023.06.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Metabolism, 2023-08. Verfasst von Xin Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Cancer Genetics, and Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians & Surgeons, Columbia University, New Yor…. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Warfarin. Die Arbeit wurde bisher 132-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Here, we identified vitamin K epoxide reductase complex subunit 1 like 1 (VKORC1L1) as a potent ferroptosis repressor. VKORC1L1 protects cells from ferroptosis by generating the reduced form of vitamin K, a potent radical-trapping antioxidant, to counteract phospholipid peroxides independent of the canonical GSH/GPX4 mechanism. Notably, we found that VKORC1L1 is also a direct transcriptional target of p53. Activation of p53 induces downregulation of VKORC1L1 expression, thus sensitizing cells to ferroptosis for tumor suppression. Interestingly, a small molecular inhibitor of VKORC1L1, warfarin, is widely prescribed as an FDA-approved anticoagulant drug. Moreover, warfarin represses tumor growth by promoting ferroptosis in both immunodeficient and immunocompetent mouse models. Thus, by downregulating VKORC1L1, p53 executes the tumor suppression function by activating an important ferroptosis pathway involved in vitamin K metabolism. Our study also reveals that warfarin is a potential repurposing drug in cancer therapy, particularly for tumors with high levels of VKORC1L1 expression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Suppressor Protein p53WarfarinAnimalsMiceAnticoagulantsVitamin KVitamin K Epoxide ReductasesMembrane Proteins

Stichwörter der Autor:innen

VKORC1L1ferroptosislipid peroxidationp53radical-trapping antioxidantstranscriptiontumor suppressionvitamin Kwarfarin

Substanzen

AnticoagulantsTumor Suppressor Protein p53Vitamin KVitamin K Epoxide ReductasesWarfarinVKORC1 protein, mouseMembrane Proteins

Autor:innen und Institutionen

  • Institute for Cancer Genetics, and Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA.
  • Department of Chemistry, Columbia University, New York, NY, USA; Mass Spectrometry Core Facility, Columbia University, New York, NY, USA.
  • Institute for Cancer Genetics, and Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA; Department of Pediatrics, and Department of Genetics and D…
  • Cell Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • Department of Chemistry, Columbia University, New York, NY, USA; Department of Biological Sciences, Columbia University, New York, NY, USA.
  • Institute for Cancer Genetics, and Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA; Department of Pathology and Cell Biology, Vagelos College…

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • National Cancer Institute
  • National Institutes of Health

Zitieren

APA

Yang, X., Wang, Z., Zandkarimi, F., Liu, Y., Duan, S., Li, Z., Kon, N., Zhang, Z., Jiang, X., Stockwell, B. R., & Gu, W. (2023). Regulation of VKORC1L1 is critical for p53-mediated tumor suppression through vitamin K metabolism. Cell Metabolism, 35(8), 1474-1490.e8. https://doi.org/10.1016/j.cmet.2023.06.014

Vancouver

Yang X, Wang Z, Zandkarimi F, Liu Y, Duan S, Li Z, et al. Regulation of VKORC1L1 is critical for p53-mediated tumor suppression through vitamin K metabolism. Cell Metabolism. 2023;35(8):1474-1490.e8. doi:10.1016/j.cmet.2023.06.014

BibTeX
@article{Yang2023,
  author = {Yang, Xin and Wang, Zhe and Zandkarimi, Fereshteh and Liu, Yanqing and Duan, Shoufu and Li, Zhiming and Kon, Ning and Zhang, Zhiguo and Jiang, Xuejun and Stockwell, Brent R and Gu, Wei},
  title = {Regulation of VKORC1L1 is critical for p53-mediated tumor suppression through vitamin K metabolism},
  journal = {Cell Metabolism},
  year = {2023},
  volume = {35},
  number = {8},
  pages = {1474--1490.e8},
  doi = {10.1016/j.cmet.2023.06.014}
}
Kostenlos starten →